Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.

ClinicalTrials.gov ID: NCT03580356

Public ClinicalTrials.gov record NCT03580356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Double-blind, Active and Placebo-controlled Study to Investigate the Efficacy and Safety of Ligelizumab (QGE031) in the Treatment of Chronic Spontaneous Urticaria (CSU) in Adolescents and Adults Inadequately Controlled With H1-antihistamines

Study identification

NCT ID
NCT03580356
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,078 participants

Conditions and interventions

Interventions

  • Ligelizumab Biological
  • Omalizumab Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2018
Primary completion
Jun 21, 2021
Completion
Jun 13, 2022
Last update posted
Jan 6, 2025

2018 – 2022

United States locations

U.S. sites
34
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
Allervie Clinical Research Birmingham Alabama 35209
Medical Resch of Arizona-Div of Allergy Asthma and Immunology Scottsdale Arizona 85251
Atria Clinical Research Asthma and Allergy Institute Little Rock Arkansas 72209
DeMera Allergy Asthma and Immun Ctr Fresno California 93720
California Allergy and Asthma Medical Group Los Angeles California 90025
Jonathan Corren Inc Los Angeles California 90025
Allergy and Asthma Consultants Redwood City California 94063
Allergy and Asthma Associates of Santa Clara Vally Center San Jose California 95117
Sarasota Clinical Research Sarasota Florida 34233
Olympian Clinical Research Tampa Florida 33609
Idaho Research Eagle Idaho 83616
Midwest Allergy Sinus Asthma SC Normal Illinois 61761
John Hopkins University Baltimore Maryland 21204
Institute for Asthma and Allergy PC Chevy Chase Maryland 20815
Chesapeake Clinical Research White Marsh Maryland 21162
Mayo Clinic Rochester Rochester Minnesota 55905
Midwest Clinical Research LcLC St Louis Missouri 63141
Montana Medical Research Missoula Montana 59808
The Asthma and Allergy Center PC Papillion Nebraska 68046
Icahn School Of Med At Mount Sinai New York New York 10029
Toledo Institute of Clinical Research Toledo Ohio 43617
Allergy Asthma and Clinical Research Oklahoma City Oklahoma 73120
PCR DBA Columbia Asthma and Allergy Clackamas Oregon 97015
Allergy and Asthma Specialists PC Blue Bell Pennsylvania 19422
Allergy and Clinical Immunology Associates Pittsburgh Pennsylvania 15241
National Allergy and Asthma Research LLS North Charleston South Carolina 29420
Bellaire Dermatology Associates Bellaire Texas 77401
Western Sky Medical Research El Paso Texas 79924
North Texas Inst For Clinical Tri Fort Worth Texas 76132
Allergy and Asthma Research Center PA San Antonio Texas 78229
Quality Assurance Research Center San Antonio Texas 78230
Allergy and Asthma Care of Waco Waco Texas 76712
Allergy Associates of Utah Sandy City Utah 84093
Bellingham Asthma Allergy and Immunology Bellingham Washington 98225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 149 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03580356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 6, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03580356 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →